Previous symbols: CMD1, CMPD1. Aliases: SRA1.
SOX9 is a SOXE-family transcription factor that plays dual core roles in development. First, SOX9 is the master regulator of chondrogenesis, cooperating with SOX5 and SOX6 to drive cartilage matrix gene expression (COL2A1, ACAN) and promoting chondrocyte differentiation while antagonizing osteoblast differentiation via beta-catenin inhibition. Second, SOX9 is critical for oligodendrocyte differentiation and glial fate specification, promoting glial over neuronal fates in the CNS. SOX9 binds AACAAT-centered DNA motifs via its HMG-box domain, bends DNA, and recruits co-activators CBP/p300 and TIP60. It functions exclusively in the nucleus with nuclear localization and export signals. Post-translational modifications including phosphorylation, acetylation, and sumoylation regulate its activity. While SOX9 has additional developmental roles in sex determination, heart valve, kidney, and other epithelial programs, its core molecular functions center on transcriptional activation in cartilage and glial lineages.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| 46,XX testicular disorder of sex development | causative germline |
mechanism: SOX9 enhancer dosage gain
subtype: SRXX2
scoped to subtype: SRXX2
|
| 46,XY complete gonadal dysgenesis | causative germline |
mechanism: SRY-SOX9-SOX8-DMRT1 transcriptional network failure
subtype: SOX9-regulatory deletion complete gonadal dysgenesis
|
| Campomelic Dysplasia | causative germline |
mechanism: Disrupted 46,XY Sex Determination; SOX9-Mediated Chondrogenesis Disruption
|
| Isolated Pierre Robin Syndrome |
untyped
Regulatory target of pathogenic noncoding deletions in a subset of isolated Robin sequence
|
mechanism: Modular Loss of SOX9 Expression in Cranial Neural Crest
subtype: SOX9 regulatory
scoped to subtype: SOX9 regulatory
|
| Fetal Valproate Syndrome | no genetic record |
mechanism: Disturbed Cranial Neural Crest Formation and Migration
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| Cooks syndrome MONDO:0007134 | AD | Limited 2020-09-16 |
Cooks Syndrome
not named
|
| campomelic dysplasia MONDO:0007251 | AD | Definitive 2020-06-01 |
Campomelic Dysplasia
causative
|
| isolated Pierre-Robin syndrome MONDO:0009869 | AD | Limited 2024-08-06 |
Isolated Pierre Robin Syndrome
untyped
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.